43 THORNDIKE STREET, CAMBRIDGE, MA
Election of Class II Directors at Amylyx Pharmaceuticals Annual Meeting
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Investor Presentation
Financial Results, Press Release
Reports Third Quarter 2025 Financial Results
News, Underwriting Agreement, Legal Opinion
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report